fontaine zink

23
Update on Diarrhoea Management What is New? O. Fontaine, WHO – Geneva On behalf of the Zinc task Force A Workshop to Support the Introduction of Zinc as part of Diarrhoea Management in Indonesia Jakarta, Indonesia 26-28 September 2006

Upload: ashadi

Post on 03-Jun-2015

532 views

Category:

Health & Medicine


4 download

TRANSCRIPT

Page 1: Fontaine Zink

Update on Diarrhoea Management

What is New?

O. Fontaine, WHO – GenevaOn behalf of the Zinc task Force

A Workshop to Support the Introduction of Zinc as part of Diarrhoea Management in Indonesia

Jakarta, Indonesia

26-28 September 2006

Page 2: Fontaine Zink

Epidemiology

Page 3: Fontaine Zink

Diarrhoea Mortality

• 1980: 4.6 million child deaths from diarrhoea

• 2003: 1.8 million child deaths from diarrhoea

Black, Morris, Bryce. Lancet 2003.

Jones, Steketee, Black et al. Lancet 2003.

Page 4: Fontaine Zink
Page 5: Fontaine Zink
Page 6: Fontaine Zink

Diarrhoea prevalence in under-five children by socioeconomic status in

selected countries

0

5

10

15

20

25

30

Bangladesh Viet Nam Benin Tanzania

Country

Dia

rrh

oea p

revale

nce

Poorest 20%

Richest 20%

Page 7: Fontaine Zink

Diarrhoea Treatment Policy

Page 8: Fontaine Zink

Global Diarrhoea Treatment Policy

• Treatment of dehydration with ORS solution (or with an intravenous electrolyte solution in cases of severe dehydration)

• Continue feeding or increase breastfeeding during , and increase feeding after the diarrhoeal episode

• Use antibiotics only when appropriate (i.e. bloody diarrhoea) and abstain from administering anti-diarrhoeal drugs

• Advise mothers of the need to increase fluids and continue feeding during future episodes

• Provide children with 20mg per day of zinc for 10-14 days

WHO/UNICEF. Joint statement on the clinical management of acute diarrhoea. 2004.

Page 9: Fontaine Zink

Global Diarrhoea Treatment Policy

• Treatment of dehydration with ORS solution (or with an intravenous electrolyte solution in cases of severe dehydration)

• Continue feeding or increase breastfeeding during , and increase feeding after the diarrhoeal episode

• Use antibiotics only when appropriate (i.e. bloody diarrhoea) and abstain from administering anti-diarrhoeal drugs

• Advise mothers of the need to increase fluids and continue feeding during future episodes

• Provide children with 20mg per day of zinc for 10-14 days

WHO/UNICEF. Joint statement on the clinical management of acute diarrhoea. 2004.

Page 10: Fontaine Zink

Global Diarrhoea Treatment Policy

• Treatment of dehydration with ORS solution (or with an intravenous electrolyte solution in cases of severe dehydration)

• Continue feeding or increase breastfeeding during , and increase feeding after the diarrhoeal episode

• Use antibiotics only when appropriate (i.e. bloody diarrhoea) and abstain from administering anti-diarrhoeal drugs

• Advise mothers of the need to increase fluids and continue feeding during future episodes

• Provide children with 20mg per day of zinc for 10-14 days

WHO/UNICEF. Joint statement on the clinical management of acute diarrhoea. 2004.

Page 11: Fontaine Zink

Recent Scientific Advancesabout Zinc in the Treatment of

Diarrhoea

Page 12: Fontaine Zink

Zinc for the Treatment of DiarrhoeaHistory of Research

• Ongoing research from the 1990s until today

• 13 trials in acute diarrhoea

• 5 trials in persistent diarrhoea

• Age groups: 3-60 mo

• Dose of zinc: ≈ 20 mg/d (range 5-45 mg/d)

Page 13: Fontaine Zink

Zinc for the Treatment of DiarrhoeaResearch Findings

• 15% reduction in duration of acute diarrhoea

• 24% reduction in duration of persistent diarrhoea

• 42% reduction in treatment failure or death in persistent diarrhoea

Zinc Investigators’ Collaborative Group. AJCN 2000.

Page 14: Fontaine Zink

Effect of Zinc Supplementation on Duration of Acute Diarrhoea/Time to Recovery

*Bangladesh, 1999

Pooled

1*Difference in mean and 95% CI

Relative Hazards and 95% CI

*India, 1988

*India, 2000*Brazil, 2000*India, 2001

Indonesia, 1998India, 1995

Bangladesh, 1997India, 2001

India, 2001

Nepal, 2001

Bangladesh, 2001

Page 15: Fontaine Zink

Therapeutic Effects of Zinc on Diarrhoea Severity

CountryDiarrhoea Outcome

Percent Reduction

India Frequency 18

India Frequency 39

Bangladesh Output 28

India Output 38

Brazil Frequency 59

Page 16: Fontaine Zink

Additional Preventive Aspects of Zinc Treatment

• Zinc supplementation for 10-14 days has longer term effects on childhood illnesses in the 2-3 months after treatment

• 34% reduction in prevalence of diarrhoea

• 26% reduction in incidence of pneumonia

Zinc Investigators’ Collaborative Group. Pediatrics. 1999.

Page 17: Fontaine Zink

Preventive Effect of Zinc Supplementation on Diarrhoea Incidence in Short - Course

Supplementation Trials Bangladesh (I)

Bangladesh (II)

Pakistan

Bangladesh (III)

Pooled

0 0.25 0.5 0.75 1 1.25 1.5 1.75 2 2.25 2.5

Odds Ratio and 95% CI

Page 18: Fontaine Zink

Community-based Trial Demonstrates Zinc Effectiveness in

Treating Diarrhoea

• 30 health worker areas in rural Bangladesh randomized to ORS alone or ORS + zinc (20mg/d for 14 days) for diarrhoea treatment

• 11,880 child-years of observation during the 2 year study

• 23% decrease in duration of all diarrhoea episodes in zinc treatment clusters compared to control clusters (RH 0.77, 95% CI 0.69-0.86)

Baqui, Black, Arifeen. BMJ 2003.

Page 19: Fontaine Zink

Community-based Trial Demonstrates Longer-term Benefits of Zinc

• Zinc supplementation decreased:• Overall diarrhoea prevalence by 15% (RR

0.85, 95% CI: 0.76, 0.96)• Hospitalization from diarrhoea by 19% (RR

0.81, 95% CI: 0.65, 1.00)• ALRI prevalence by 7% (RR 0.93, 95% CI:

0.78, 1.10)• Hospitalization from ALRI by 19% (RR 0.81,

95% CI: 0.53, 1.23)

Page 20: Fontaine Zink

Community-based Trial Demonstrates Longer-term Benefits

of Zinc

• Decreased overall mortality by 51% (RR 0.49 95% CI: 0.25, 0.94), non-injury deaths

• Decreased antibiotic use rate from 34% in control clusters to 13% in zinc clusters (p<0.01)

• Increased ORS use from 50% in control clusters to 75% in zinc clusters (p<0.01)

Page 21: Fontaine Zink

Safety of Zinc Supplementation

• 9,100 children less than 5 years of age studied in 18 published clinical trials

• 11,880 child yrs of observation in 1 large community trial

• Vomiting is the only reported adverse effect– 5/7 trials report no differences between zinc and

placebo– 2 trials report slightly higher vomiting rates in zinc

supplemented children

• 4 trials show no difference in copper status after 2 weeks of zinc supplementation

Page 22: Fontaine Zink

Cost Effectiveness of ORS and Zinc Supplementation

• Decreases the duration and severity of the episode

• Decreases the need for expensive hospitalization

• Decreases the use of unnecessary antibiotics and other drugs

• Further cost-benefit analyses are underway• Robberstad, Strand, Sommerfelt, and Black. Bull WHO 2004.

Baqui, Black, Arifeen. J Health Pop Nutr. 2004.

Page 23: Fontaine Zink

ORS and Zinc

Treatment is now more effective

This is the chance to make a difference